Cayuga Biotech
NY - New YorkBiotechnology
Focus: Cayuga Biotech is a newly founded (2024) biotechnology company headquartered in New York specializing in hemostasis treatments. The company is publicly listed but remains in early-stage development with no disclosed revenue or active clinical programs.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Cayuga Biotech
AI assessmentNot HiringNo open roles listed right now. Follow Cayuga Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CAY001
HealthyClinical Trials (1)
NCT06845839Study to Evaluate CAY001 in Healthy Volunteers
Phase 1Help build intelligence for Cayuga Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.